BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 36383109)

  • 21. Identification of six candidate genes for endometrial carcinoma by bioinformatics analysis.
    Zhu Y; Shi L; Chen P; Zhang Y; Zhu T
    World J Surg Oncol; 2020 Jul; 18(1):161. PubMed ID: 32641130
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bioinformatics analyses of significant genes, related pathways and candidate prognostic biomarkers in glioblastoma.
    Zhou L; Tang H; Wang F; Chen L; Ou S; Wu T; Xu J; Guo K
    Mol Med Rep; 2018 Nov; 18(5):4185-4196. PubMed ID: 30132538
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification of Core Prognosis-Related Candidate Genes in Chinese Gastric Cancer Population Based on Integrated Bioinformatics.
    Li M; Wang X; Liu J; Mao X; Li D; Wang Z; Tang Y; Wu S
    Biomed Res Int; 2020; 2020():8859826. PubMed ID: 33381592
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification of potential hub genes of gastric cancer.
    Zhou XD; Qu YW; Wang L; Jia FH; Chen P; Wang YP; Liu HF
    Medicine (Baltimore); 2022 Oct; 101(41):e30741. PubMed ID: 36254003
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification and validation of core genes in tumor-educated platelets for human gastrointestinal tumor diagnosis using network-based transcriptomic analysis.
    Jiang Y; He J; Wang X; Liu C; Zhou W; Liu D; Guo Z; Liu K
    Platelets; 2023 Dec; 34(1):2212071. PubMed ID: 37212262
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A senescence-based prognostic gene signature for colorectal cancer and identification of the role of SPP1-positive macrophages in tumor senescence.
    Yu S; Chen M; Xu L; Mao E; Sun S
    Front Immunol; 2023; 14():1175490. PubMed ID: 37090726
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification and Analysis of Key Genes Driving Gastric Cancer Through Bioinformatics.
    Liu Z; Liu S; Guo J; Sun L; Wang S; Wang Y; Qiu W; Lv J
    Genet Test Mol Biomarkers; 2021 Jan; 25(1):1-11. PubMed ID: 33470887
    [No Abstract]   [Full Text] [Related]  

  • 28. Identification of core genes and outcomes in hepatocellular carcinoma by bioinformatics analysis.
    Shen S; Kong J; Qiu Y; Yang X; Wang W; Yan L
    J Cell Biochem; 2019 Jun; 120(6):10069-10081. PubMed ID: 30525236
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Derivation and Validation of the Potential Core Genes in Pancreatic Cancer for Tumor-Stroma Crosstalk.
    Xue R; Hua L; Xu W; Gao Y; Pang Y; Hao J
    Biomed Res Int; 2018; 2018():4283673. PubMed ID: 30519576
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Screening and Survival Analysis of Hub Genes in Gastric Cancer Based on Bioinformatics.
    Zheng S; Yang L; Dai Y; Jiang L; Wei Y; Wen H; Xu Y
    J Comput Biol; 2019 Nov; 26(11):1316-1325. PubMed ID: 31233344
    [No Abstract]   [Full Text] [Related]  

  • 31. Integrated analysis of a ceRNA network reveals potential prognostic lncRNAs in gastric cancer.
    Qi M; Yu B; Yu H; Li F
    Cancer Med; 2020 Mar; 9(5):1798-1817. PubMed ID: 31923354
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Transcriptome analysis reveals GPNMB as a potential therapeutic target for gastric cancer.
    Ren F; Zhao Q; Liu B; Sun X; Tang Y; Huang H; Mei L; Yu Y; Mo H; Dong H; Zheng P; Mi Y
    J Cell Physiol; 2020 Mar; 235(3):2738-2752. PubMed ID: 31498430
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification of Key Genes and Pathways in Tongue Squamous Cell Carcinoma Using Bioinformatics Analysis.
    Zhang H; Liu J; Fu X; Yang A
    Med Sci Monit; 2017 Dec; 23():5924-5932. PubMed ID: 29240723
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Screening key genes and biomarkers in gastrointestinal metaplasia that progress to gastric cancer by integrated bioinformatics analysis.
    Pang L; Yan X; Su D
    J Physiol Pharmacol; 2021 Dec; 72(6):. PubMed ID: 35485356
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Integrated bioinformatics analysis for the screening of hub genes and therapeutic drugs in ovarian cancer.
    Yang D; He Y; Wu B; Deng Y; Wang N; Li M; Liu Y
    J Ovarian Res; 2020 Jan; 13(1):10. PubMed ID: 31987036
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification of molecular marker associated with ovarian cancer prognosis using bioinformatics analysis and experiments.
    Zheng MJ; Li X; Hu YX; Dong H; Gou R; Nie X; Liu Q; Ying-Ying H; Liu JJ; Lin B
    J Cell Physiol; 2019 Jul; 234(7):11023-11036. PubMed ID: 30633343
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification of Potential Hub Genes and Therapeutic Drugs in Malignant Pleural Mesothelioma by Integrated Bioinformatics Analysis.
    Zhang X; Yang L; Chen W; Kong M
    Oncol Res Treat; 2020; 43(12):656-671. PubMed ID: 33032291
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bioinformatics-Based Identification of Methylated-Differentially Expressed Genes and Related Pathways in Gastric Cancer.
    Li H; Liu JW; Liu S; Yuan Y; Sun LP
    Dig Dis Sci; 2017 Nov; 62(11):3029-3039. PubMed ID: 28914394
    [TBL] [Abstract][Full Text] [Related]  

  • 39. COL5A2 is a prognostic-related biomarker and correlated with immune infiltrates in gastric cancer based on transcriptomics and single-cell RNA sequencing.
    Chen M; Zhu X; Zhang L; Zhao D
    BMC Med Genomics; 2023 Sep; 16(1):220. PubMed ID: 37723519
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Detection of critical genes associated with poor prognosis in breast cancer via integrated bioinformatics analyses.
    Liu D; Zhang J; Li L; Wang Q; Lan Y
    J BUON; 2020; 25(6):2537-2545. PubMed ID: 33455094
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.